William Blair & Company’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $633K | Buy |
239,814
+6,314
| +3% | +$16.7K | ﹤0.01% | 1021 |
|
|
2025
Q1 | $703K | Hold |
233,500
| – | – | ﹤0.01% | 981 |
|
|
2024
Q4 | $598K | Buy |
233,500
+26,700
| +13% | +$68.4K | ﹤0.01% | 1043 |
|
|
2024
Q3 | $769K | Hold |
206,800
| – | – | ﹤0.01% | 983 |
|
|
2024
Q2 | $1.31M | Sell |
206,800
-106,742
| -34% | -$675K | ﹤0.01% | 801 |
|
|
2024
Q1 | $1.68M | Buy |
313,542
+161,530
| +106% | +$867K | 0.01% | 722 |
|
|
2023
Q4 | $763K | Sell |
152,012
-10,450
| -6% | -$52.5K | ﹤0.01% | 946 |
|
|
2023
Q3 | $275K | Buy |
162,462
+108,431
| +201% | +$183K | ﹤0.01% | 1271 |
|
|
2023
Q2 | $150K | Buy |
54,031
+1,000
| +2% | +$2.78K | ﹤0.01% | 1457 |
|
|
2023
Q1 | $96.5K | Hold |
53,031
| – | – | ﹤0.01% | 1507 |
|
|
2022
Q4 | $269K | Sell |
53,031
-500
| -0.9% | -$2.54K | ﹤0.01% | 1272 |
|
|
2022
Q3 | $266K | Hold |
53,531
| – | – | ﹤0.01% | 1277 |
|
|
2022
Q2 | $199K | Buy |
53,531
+20,531
| +62% | +$76.3K | ﹤0.01% | 1422 |
|
|
2022
Q1 | $185K | Hold |
33,000
| – | – | ﹤0.01% | 1538 |
|
|
2021
Q4 | $201K | Hold |
33,000
| – | – | ﹤0.01% | 1572 |
|
|
2021
Q3 | $321K | Buy |
33,000
+8,000
| +32% | +$77.8K | ﹤0.01% | 1321 |
|
|
2021
Q2 | $357K | Buy |
25,000
+8,000
| +47% | +$114K | ﹤0.01% | 1280 |
|
|
2021
Q1 | $404K | Buy |
+17,000
| New | +$404K | ﹤0.01% | 1217 |
|